GSEP
RMD icon

Golden State Equity Partners’s ResMed RMD Stock Holding History

Golden State Equity Partners’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-61
Closed -$13.7K – 1447
2026
Q1 		$13.7K Buy
+61
New +$15.2K ﹤0.01% 1210
2024
Q4 		– Sell
-22
Closed -$5.37K – 777
2024
Q3 		$5.37K Buy
+22
New +$4.92K ﹤0.01% 762

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Golden State Equity Partners's RMD Position: Q2 2026 in Review

Golden State Equity Partners sold out of ResMed (RMD) in Q2 2026, closing a stake of 61 shares — an estimated $13.7K sold.

Golden State Equity Partners first reported a position in RMD in Q3 2024 and held it in 2 quarters. The position peaked at $13.7K in Q1 2026. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Golden State Equity Partners reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • Golden State Equity Partners sold 61 ResMed shares in Q2 2026, an estimated $13.7K.
  • Golden State Equity Partners first reported a position in ResMed in Q3 2024 and held it in 2 quarters.
  • Golden State Equity Partners's ResMed position peaked at $13.7K in Q1 2026.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Golden State Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.